Whole Brain Irradiation for Metastases from Lung Carcinoma
Open Access
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Acta Radiologica: Oncology
- Vol. 24 (4) , 311-314
- https://doi.org/10.3109/02841868509136057
Abstract
Sixty-nine consecutive patients with brain metastases from lung carcinoma were randomly allocated to one of two radiation therapy schedules: 30 Gy/10 fractions/2 weeks or 50 Gy/20 fractions/4 weeks. The improvement rate for neurologic function was similar in the two groups. The median survival times for patients receiving the short course and the long course were 4 months and 3 months, respectively. The half-year survival rate was 42 per cent after the short course and 14 per cent after the long course (p<0.05). Performance status and lactate dehydrogenase were other factors which significantly influenced the half-year survival rate.This publication has 6 references indexed in Scilit:
- The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Results of re-irradiation for cerebral metastasesCancer, 1980
- Intracranial metastases: Behavioral patterns related to primary site and results of treatment by whole brain irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Recent application of quantification II in Japanese medical research.Environmental Health Perspectives, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958